Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cilostazol for Prevention of Recurrent Stroke Trial

NCT07174414 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07174414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cilostazol for Prevention of Recurrent Stroke Trial
Lead sponsor
Stanford University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
July 31, 2031
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, myocardial infarction, recurrent stroke, stroke (cva) or transient ischemic attack, stroke recurrence, tia (transient ischemic attack), vascular death